Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 3Breast Neoplasms 3Polycythemia Vera 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymic aplasia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Dysautonomias 1Polycystic Ovary Syndrome 1Neuroblastoma 1Neoplasms 1Mucopolysaccharidosis I 1Metabolic Syndrome 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Immunologic Deficiency Syndromes 1Hyperandrogenism 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

enzalutamide 1bicalutamide 1Receptors, Androgen 1Phlebotomy 1Leuprolide 1Goserelin 1Flutamide 1Ethinyl Estradiol 1Cyproterone Acetate 1Bloodletting 1Blood Donation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Primary Dysautonomias × Phlebotomy × Clear all
NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase NA Completed
37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡